UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,611 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Two real estate giants are dueling over how data is distributed. As Compass leans on MLS access to push its agenda, o...
Chewy has shown growth in revenue alongside margin pressures as it scales its e-commerce pet-products platform. This ...
Micron Technology has been a market darling, but a different S&P 500 stock has surged even more this year. This guide...
SK hynix prepares to begin trading on Nasdaq with ADRs priced at $149, in a move that broadens access to AI memory ex...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Bitcoin is navigating a volatile path, but a decade-long horizon can reveal meaningful possibilities. This guide brea...
Oracle is pursuing aggressive growth through heavy spending. This article breaks down the rationale, the risks, and w...
Retirement can feel fragile when the economy wobbles. Learn how to recession-proof your retirement income with proven...
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
Hesai's early 2026 earnings signal a turning point for LiDAR tech adoption. This guide breaks down the Q1 results, wh...